We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Guidelines for Determining Brain Death Released

By HospiMedica International staff writers
Posted on 23 Jun 2010
The American Academy of Neurology (AAN; Saint Paul, MN, USA) has issued updated guidelines for determining brain death in adults for the first time in 15 years, providing step-by-step instructions to guide clinical decision making.

Researchers from the Mayo Clinic (Rochester, MN, USA), the University of Kansas (Kansas City, USA), and from Massachusetts General Hospital (MGH; Boston, USA) did a systematic literature search to find data for an update to the 1995 ANN brain death guideline. More...
The researchers included a review of Medline and Embase studies from January 1996 to May 2009, which were limited to adults. The aim of the study was to answer the following questions: Are there patients who fulfill the clinical criteria of brain death who recover neurologic function? What is an adequate observation period to ensure that cessation of neurologic function is permanent? Are complex motor movements that falsely suggest retained brain function sometimes observed in brain death? What is the comparative safety of techniques for determining apnea? Are there new ancillary tests that accurately identify patients with brain death?

The researchers reported that new data have confirmed the effectiveness of earlier recommendations, and saw no evidence of recovery of neurologic function after a diagnosis of brain death, using the criteria from the 1995 practice parameter. The authors also found that in adults, complex-spontaneous motor movements and false-positive triggering of the ventilator may occur in patients who are brain dead; accordingly, there is insufficient evidence to determine the minimally acceptable observation period to ensure that neurologic functions have ceased irreversibly.

Additionally, apneic oxygenation diffusion to determine apnea is safe, but there is insufficient evidence to determine the comparative safety of techniques used for apnea testing. In addition, the researchers reported that there is insufficient evidence to determine if newer ancillary tests accurately confirm the cessation of function of the entire brain. An important clarification in the new guidelines, however, is that more than one comprehensive exam is not required for determining brain death. The new guidelines were published in the June 8, 2010, issue of Neurology.

"The brain death diagnosis can be made only after a comprehensive clinical evaluation and often involves more than 25 separate assessments,” said lead author Eelco Wijdicks, M.D., of the Mayo Clinic. "I think some people will be disappointed that we weren't able to nail this down, but this will be highly variable patient to patient, and there is no general rule.”

"To correctly diagnose brain death, it is essential clinicians adhere to a uniform framework,” added study coauthor Gary Gronseth, M.D., of the University of Kansas. "We wanted to provide useful tools to help clinicians, but many factors will still need to be based on clinical judgment.”

Brain death is a legal indicator of death that refers to the irreversible end of all brain activity due to total necrosis of the cerebral neurons due to loss of blood flow and oxygenation. Brain-stem death is considered to be the significant point, when the brain is no longer capable of sustaining the rest of the body's systems without advanced life support. The concept of brain death emerged in the 1960s, as the ability to resuscitate individuals and mechanically keep the heart and lungs functioning became prevalent.

Related Links:
American Academy of Neurology
Mayo Clinic
University of Kansas
Massachusetts General Hospital


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.